We identified PARP1 as a novel biomarker for HCC and demonstrated that a panel composed by NDRG1, GS, and PARP1 is very useful in distinguishing between CLs, DNs and HCCs. This evidence concerns the gene PARP1 and hepatocellular carcinoma.